182 related articles for article (PubMed ID: 28689023)
1. Profiling of cytokines, chemokines and other soluble proteins as a potential biomarker in colorectal cancer and polyps.
Johdi NA; Mazlan L; Sagap I; Jamal R
Cytokine; 2017 Nov; 99():35-42. PubMed ID: 28689023
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I--an independent prognostic factor.
Kaminska J; Nowacki MP; Kowalska M; Rysinska A; Chwalinski M; Fuksiewicz M; Michalski W; Chechlinska M
Tumour Biol; 2005; 26(4):186-94. PubMed ID: 16006772
[TBL] [Abstract][Full Text] [Related]
3. Plasma cytokine levels and the presence of colorectal cancer.
Yamaguchi M; Okamura S; Yamaji T; Iwasaki M; Tsugane S; Shetty V; Koizumi T
PLoS One; 2019; 14(3):e0213602. PubMed ID: 30883594
[TBL] [Abstract][Full Text] [Related]
4. Serum TEM5 and TEM7 concentrations correlate with clinicopathologic features and poor prognosis of colorectal cancer patients.
Pietrzyk Ł; Wdowiak P
Adv Med Sci; 2019 Sep; 64(2):402-408. PubMed ID: 31352222
[TBL] [Abstract][Full Text] [Related]
5. Intake consumption of ginsenoside Rg3, profiling of selected cytokines, and development of rectal polyps.
Xie J; Luo S; Mi H; Du Y; Bao G; Zhou J; Xi Y; Li C
Cancer Manag Res; 2019; 11():4059-4064. PubMed ID: 31190981
[No Abstract] [Full Text] [Related]
6. Serum biomarkers in head and neck squamous cell cancer.
Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
[TBL] [Abstract][Full Text] [Related]
7. Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma.
Henry CJ; Sedjo RL; Rozhok A; Salstrom J; Ahnen D; Levin TR; D'Agostino R; Haffner S; DeGregori J; Byers T
BMC Cancer; 2015 Mar; 15():123. PubMed ID: 25884547
[TBL] [Abstract][Full Text] [Related]
8. Changes of plasma cytokines and chemokines expression level in nasopharyngeal carcinoma patients after treatment with definitive intensity-modulated radiotherapy (IMRT).
Jin YB; Zhang GY; Lin KR; Chen XP; Cui JH; Wang YJ; Luo W
PLoS One; 2017; 12(2):e0172264. PubMed ID: 28207826
[TBL] [Abstract][Full Text] [Related]
9. Serological Markers Associated With Response to Immune Checkpoint Blockade in Metastatic Gastrointestinal Tract Cancer.
Lu Z; Zou J; Hu Y; Li S; Zhou T; Gong J; Li J; Zhang X; Zhou J; Lu M; Wang X; Peng Z; Qi C; Li Y; Li J; Li Y; Zou J; Du X; Zhang H; Shen L
JAMA Netw Open; 2019 Jul; 2(7):e197621. PubMed ID: 31339548
[TBL] [Abstract][Full Text] [Related]
10. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
Sánchez-Zauco N; Torres J; Gómez A; Camorlinga-Ponce M; Muñoz-Pérez L; Herrera-Goepfert R; Medrano-Guzmán R; Giono-Cerezo S; Maldonado-Bernal C
BMC Cancer; 2017 May; 17(1):384. PubMed ID: 28558708
[TBL] [Abstract][Full Text] [Related]
11. Development of an enzyme-linked immunosorbent assay for detection of CDCP1 shed from the cell surface and present in colorectal cancer serum specimens.
Chen Y; Harrington BS; Lau KCN; Burke LJ; He Y; Iconomou M; Palmer JS; Meade B; Lumley JW; Hooper JD
J Pharm Biomed Anal; 2017 May; 139():65-72. PubMed ID: 28279929
[TBL] [Abstract][Full Text] [Related]
12. [Inflammatory factors promote the development of colorectal cancer].
Guo Q; Shen S; Li X; Tang K; Zhou W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 36(7):646-9. PubMed ID: 21873790
[TBL] [Abstract][Full Text] [Related]
13. Histone-lysine N-methyltransferase SETD7 is a potential serum biomarker for colorectal cancer patients.
Duan B; Bai J; Qiu J; Wang J; Tong C; Wang X; Miao J; Li Z; Li W; Yang J; Huang C
EBioMedicine; 2018 Nov; 37():134-143. PubMed ID: 30361067
[TBL] [Abstract][Full Text] [Related]
14. Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis.
Lim LC; Looi ML; Zakaria SZ; Sagap I; Rose IM; Chin SF; Jamal R
Pathol Oncol Res; 2016 Jan; 22(1):169-77. PubMed ID: 26463353
[TBL] [Abstract][Full Text] [Related]
15. Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1.
Heijmans-Antonissen C; Wesseldijk F; Munnikes RJ; Huygen FJ; van der Meijden P; Hop WC; Hooijkaas H; Zijlstra FJ
Mediators Inflamm; 2006; 2006(1):28398. PubMed ID: 16864900
[TBL] [Abstract][Full Text] [Related]
16. Blood-based protein biomarker panel for the detection of colorectal cancer.
Fung KY; Tabor B; Buckley MJ; Priebe IK; Purins L; Pompeia C; Brierley GV; Lockett T; Gibbs P; Tie J; McMurrick P; Moore J; Ruszkiewicz A; Nice E; Adams TE; Burgess A; Cosgrove LJ
PLoS One; 2015; 10(3):e0120425. PubMed ID: 25793510
[TBL] [Abstract][Full Text] [Related]
17. Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients.
Ito H; Miki C
Scand J Gastroenterol; 1999 Nov; 34(11):1139-43. PubMed ID: 10582766
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma.
Radosavljevic G; Ljujic B; Jovanovic I; Srzentic Z; Pavlovic S; Zdravkovic N; Milovanovic M; Bankovic D; Knezevic M; Acimovic LJ; Arsenijevic N
Neoplasma; 2010; 57(2):135-44. PubMed ID: 20099977
[TBL] [Abstract][Full Text] [Related]
19. Serum level of endothelial cell-specific molecule-1 and prognosis of colorectal cancer.
Jiang H; Fu XG; Chen YT
Genet Mol Res; 2015 May; 14(2):5519-26. PubMed ID: 26125749
[TBL] [Abstract][Full Text] [Related]
20. A novel mixed integer programming for multi-biomarker panel identification by distinguishing malignant from benign colorectal tumors.
Zou M; Zhang PJ; Wen XY; Chen L; Tian YP; Wang Y
Methods; 2015 Jul; 83():3-17. PubMed ID: 25980368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
